SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on August 3, 2022. The report discloses a material corporate event regarding executive leadership changes. Note: The request metadata referenced "Vivani Medical, Inc.," but the filing text explicitly identifies the registrant as Second Sight Medical Products, Inc.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It is a current report focused solely on personnel changes.
Material Changes
- Executive Departure: Edward Randolph, Chief Operating Officer (COO), notified the company of his resignation effective August 19, 2022.
- Tenure: Mr. Randolph had served the company since 2007.
- Reason for Departure: The resignation did not result from any disagreement with the company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. The document confirms that Scott Dunbar is serving as the Acting Chief Executive Officer and signed the report on August 5, 2022.
Investor Verification Checklist
- Verify the appointment of a permanent Chief Operating Officer to replace Edward Randolph.
- Review subsequent filings for any transition plans or interim leadership structures.
- Confirm the status of the Acting CEO, Scott Dunbar, and whether a permanent CEO has been appointed.
- Check for any related press releases detailing the strategic impact of the COO departure.